DE69323090T2 - 4-ALKOXY-2,6-DI-t-BUTYLPHENOLDERIVATE - Google Patents

4-ALKOXY-2,6-DI-t-BUTYLPHENOLDERIVATE

Info

Publication number
DE69323090T2
DE69323090T2 DE69323090T DE69323090T DE69323090T2 DE 69323090 T2 DE69323090 T2 DE 69323090T2 DE 69323090 T DE69323090 T DE 69323090T DE 69323090 T DE69323090 T DE 69323090T DE 69323090 T2 DE69323090 T2 DE 69323090T2
Authority
DE
Germany
Prior art keywords
tert
butyl
acetoxy
mixture
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69323090T
Other languages
German (de)
English (en)
Other versions
DE69323090D1 (de
Inventor
Osamu Cynshi
Yoshiaki Kato
Yasuhiro Ohba
Kunio Tamura
Mitsutaka Chugai Seiyaku Kabushiki Kaisha Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE69323090D1 publication Critical patent/DE69323090D1/de
Application granted granted Critical
Publication of DE69323090T2 publication Critical patent/DE69323090T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69323090T 1992-10-16 1993-10-18 4-ALKOXY-2,6-DI-t-BUTYLPHENOLDERIVATE Expired - Fee Related DE69323090T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32110192 1992-10-16
PCT/JP1993/001489 WO1994008930A1 (fr) 1992-10-16 1993-10-18 DERIVE DE 4-ALCOXY-2,6-DI-t-BUTHYLPHENOL

Publications (2)

Publication Number Publication Date
DE69323090D1 DE69323090D1 (de) 1999-02-25
DE69323090T2 true DE69323090T2 (de) 2000-01-27

Family

ID=18128834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69323090T Expired - Fee Related DE69323090T2 (de) 1992-10-16 1993-10-18 4-ALKOXY-2,6-DI-t-BUTYLPHENOLDERIVATE

Country Status (14)

Country Link
US (3) US5574178A (enExample)
EP (1) EP0665208B1 (enExample)
KR (1) KR100247213B1 (enExample)
CN (1) CN1054128C (enExample)
AT (1) ATE175658T1 (enExample)
AU (1) AU6241894A (enExample)
CA (1) CA2147263C (enExample)
DE (1) DE69323090T2 (enExample)
DK (1) DK0665208T3 (enExample)
ES (1) ES2128440T3 (enExample)
GR (1) GR3029810T3 (enExample)
SG (1) SG49937A1 (enExample)
TW (1) TW393475B (enExample)
WO (1) WO1994008930A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995029906A1 (en) * 1994-04-28 1995-11-09 Meiji Milk Products Co., Ltd. Benzofuran derivative and use thereof
US5674876A (en) * 1995-01-20 1997-10-07 Research Development Foundation ρ-heteroatom-substituted phenols and uses thereof
EP0749972A1 (en) * 1995-06-21 1996-12-27 Merrell Pharmaceuticals Inc. A process for preparing 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
TW565558B (en) 1995-11-09 2003-12-11 Chugai Pharmaceutical Co Ltd Intimal thickening inhibitory agent
US6133279A (en) * 1996-06-26 2000-10-17 Chugai Seiyaku Kabushiki Kaisha Therapeutic agents for renal diseases and organ preservatives
EP0942896B1 (en) * 1996-11-20 2003-04-16 Aventis Pharmaceuticals Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US5679820A (en) * 1996-12-16 1997-10-21 General Electric Company Silylated ultraviolet light absorbers having resistance to humidity
CA2289676A1 (en) * 1997-05-08 1998-11-12 Chugai Seiyaku Kabushiki Kaisha Prophylactic/therapeutic agents for atherosclerosis
TW472051B (en) * 1997-05-23 2002-01-11 Chugai Pharmaceutical Co Ltd 2,3-dihydrobenzofuran derivatives
AU2571400A (en) * 1999-02-23 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Seam soft capsule preparations containing dihydrobenzofuran derivative
DE19941595A1 (de) * 1999-09-01 2001-03-08 Basf Ag Verwendung von anellierten Benzolderivaten als Antioxidans oder Radikalfänger in kosmetischen Zubereitungen
AU2001272770A1 (en) 2000-07-19 2002-01-30 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of a benzofuran derivative
JPWO2003018001A1 (ja) * 2001-08-31 2004-12-09 中外製薬株式会社 アポリポタンパク質ｅの分泌促進剤
AU2003219559A1 (en) * 2002-03-29 2003-10-13 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for preventing or treating respiratory disease
US6882245B2 (en) * 2002-06-05 2005-04-19 Rf Stream Corporation Frequency discrete LC filter bank
JPWO2005030198A1 (ja) * 2003-09-26 2006-12-07 中外製薬株式会社 脂肪肝又は肝疾患を治療するための医薬組成物
CN110940747B (zh) * 2019-12-03 2022-06-28 酒泉市食品检验检测中心 一种马铃薯及其制品中α-茄碱和α-卡茄碱的测定方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3777366D1 (de) * 1986-12-27 1992-04-16 Takeda Chemical Industries Ltd 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
JPH085871B2 (ja) * 1986-12-27 1996-01-24 武田薬品工業株式会社 クマラン誘導体およびその製造法
JP2855341B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 新規２―置換クマラン誘導体
JP2855340B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 ２―置換クマラン誘導体
IT1229482B (it) * 1988-08-01 1991-09-03 Foscama Biomed Chim Farma Acidi (rs) 2 (2,3 diidro 5 idrossi 4,6,7 trimetilbenzofuranil) acetico e 2 (2,3 diidro 5 acilossi 4,6,7 trimetilbenzofuranil) acetici e loro esteri, utili come farmaci mucoregolatori ed antiischemici.
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
JPH02121975A (ja) * 1988-10-28 1990-05-09 Eisai Co Ltd ２，３−ジヒドロベンゾフラン誘導体
US5091533A (en) * 1990-03-12 1992-02-25 Merck Frosst Canada, Inc. 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors
DE4109627A1 (de) * 1991-03-23 1992-09-24 Boehringer Mannheim Gmbh Neue phenolether, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
JPH04300878A (ja) * 1991-03-28 1992-10-23 Fujirebio Inc ベンゼンジオール誘導体
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
JP3150740B2 (ja) * 1991-12-26 2001-03-26 エーザイ株式会社 ジヒドロベンゾフラン誘導体
WO1993020057A1 (en) * 1992-04-06 1993-10-14 Merrell Dow Pharmaceuticals Inc. Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols

Also Published As

Publication number Publication date
KR950703503A (ko) 1995-09-20
TW393475B (en) 2000-06-11
DE69323090D1 (de) 1999-02-25
ATE175658T1 (de) 1999-01-15
CN1112115A (zh) 1995-11-22
US5663373A (en) 1997-09-02
SG49937A1 (en) 1998-06-15
CA2147263C (en) 2004-12-21
EP0665208B1 (en) 1999-01-13
WO1994008930A1 (fr) 1994-04-28
US5574178A (en) 1996-11-12
GR3029810T3 (en) 1999-06-30
AU6241894A (en) 1994-05-09
EP0665208A4 (enExample) 1995-08-23
CN1054128C (zh) 2000-07-05
ES2128440T3 (es) 1999-05-16
KR100247213B1 (ko) 2000-03-15
EP0665208A1 (en) 1995-08-02
CA2147263A1 (en) 1994-04-28
DK0665208T3 (da) 1999-08-30
US5606089A (en) 1997-02-25

Similar Documents

Publication Publication Date Title
US5663373A (en) 4-alkoxy-2, 6-di-t-butylphenol derivatives
DE3929913A1 (de) 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
DE2726619A1 (de) Allylcarbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung
DE2440606A1 (de) Polyenverbindungen
CH494223A (de) Verfahren zur Herstellung von cyclischen äthylenisch ungesättigten Imiden durch Cyclisierung eines mono-N-substituierten a,B-äthylenisch ungesättigten cis-a,B-Säureamids
DE69525763T2 (de) 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENE, DIE LDL OXIDATION HEMMEN
EP0572489B1 (de) Ausgangsverbindungen zur herstellung von calcitriol sowie dessen abkömmlingen, verfahren zur herstellung dieser ausgangsverbindungen sowie zwischenprodukte für dieses verfahren
JP3050733B2 (ja) ４−アルコキシ−２，６−ジ−ｔ−ブチルフェノール誘導体
DE2310141A1 (de) Verfahren zur herstellung von 1phenyl-2-aminoaethanolderivaten
DE3401986A1 (de) 7-oxabicycloheptansubstituierte carbamatprostaglandin-analoge
DE3009508A1 (de) Verfahren zur herstellung von alpha -niederalkylfurocumarinen und neuartigen zwischenprodukten
DE3214828A1 (de) Phosphorverbindungen
EP0062902B1 (de) 2,3,4-Trinor-m-inter-phenylen-prostaglandin-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Präparate
DE2330333A1 (de) 9-desoxy-prosta-5,9(10),13-triensaeurederivate
DE2347172A1 (de) Prostaglandin e tief 1-synthese
DE2603541C2 (de) Phenyl- und Benzylphosphonatester und Verfahren zu ihrer Herstellung
DD201792A5 (de) Verfahren zur herstellung der 2,3,4,5-tetrahydro-1-benzoxepin-3,5-dion-derivate
KR930001324B1 (ko) 페놀 유도체의 제조방법
DE3606431A1 (de) Thiabicycloheptan-substituierte aminoprostaglandin-analoge
DE2731456A1 (de) 2-phenylindolderivate, deren herstellung und verwendung
DE60319439T2 (de) Verfahren zur herstellung von langkettigen cyclohexenonalkolen
CH683340A5 (de) Verfahren zur Herstellung von 2,2-Dimethyl-5-(2,5-Dimethylphenoxy)-Pentansäure.
DE2463432C2 (enExample)
DE1950012C2 (de) Neue tricyclische Verbindungen und deren Herstellung
EP0270481B1 (de) Neues Verfahren zur Herstellung von optisch aktiven Carbacyclin-Zwischenprodukten

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee